Cagrilintide is a long-acting, lipidated amylin analog built on a modified amino acid backbone with a fatty-acid side chain that extends its stability in laboratory formulations relative to native amylin. That lipidation step is also what makes cagrilintide one of the more demanding research peptides to synthesize cleanly, which raises rather than lowers the bar for sourcing documentation. A vial labeled \"cagrilintide\" tells a lab nothing about whether the lipid conjugation, folding, and purity were actually achieved correctly during synthesis — only independent analytical testing does that.
What to verify before ordering
- Purity ≥98% by HPLC — reported with the chromatography method and column conditions disclosed, not a bare percentage on a label. Background: HPLC purity analysis.
- Mass spectrometry identity confirmation — because cagrilintide carries a fatty-acid linker in addition to its amino acid sequence, confirming identity requires more than a single HPLC retention time match. A lot-specific mass spec result that matches the expected molecular weight for the fully lipidated analog is the only reliable way to rule out an incomplete conjugation. See HPLC vs. mass spectrometry.
- Batch-specific Certificate of Analysis — tied to the lot actually shipped, not a template reused across production runs. See how to read a COA.
- Correct lyophilized form and cold-chain handling — the lipid side chain makes cagrilintide more sensitive to improper storage or temperature excursions in transit than smaller, unmodified peptides. It should arrive lyophilized, not pre-mixed, with clear reconstitution guidance. See cagrilintide reconstitution and storage.
- Disclosed net peptide content — the gross vial weight includes counter-ions and residual moisture from lyophilization, so actual peptide mass is lower. Suppliers willing to publish net content alongside gross label weight give labs an honest basis for concentration calculations.
Why sourcing discipline matters more for this analog
Because the lipidation chemistry adds a synthesis step that simpler peptides don't require, small errors in the conjugation or purification process are more consequential here than with shorter, unmodified sequences — a partially conjugated or truncated batch can still register as \"cagrilintide\" on a basic purity check while behaving differently from the intended analog in downstream assays. For background on the underlying mechanism of action and what's actually being measured, mass spectrometry confirmation and a batch-matched COA are not optional extras for this compound; they're the only way a lab can know the material matches what the literature describes. Our own purity testing page covers the analytical methods in more detail.
Questions worth asking any supplier
- Is the COA generated per production batch, with a lot number that matches what's printed on the vial received?
- Was identity testing performed by mass spectrometry, and is that data available on request? See third-party testing explained.
- Does the supplier disclose synthesis method (solid-phase synthesis route, lipidation and purification steps) when asked directly?
- Are storage and handling instructions specific to cagrilintide's lipidated structure, or generic boilerplate copied across every product page?
- Is sale explicitly restricted to research use, with no dosing or administration guidance implying otherwise?
A supplier that can answer these without hedging, and that will produce a batch-specific COA on request, is operating the way a laboratory reagent supplier should. Vague answers or a refusal to provide lot-matched documentation are reasons to source elsewhere.
Price relative to documentation
Cagrilintide is more expensive to synthesize correctly than most unmodified research peptides because of the added lipidation chemistry and the extra purification steps needed to achieve high purity at that complexity. Pricing that undercuts the market significantly while still claiming ≥98% HPLC purity and mass-spec-confirmed identity is worth scrutinizing — at minimum, ask to see the actual batch COA before assuming the claim is accurate. For general criteria that apply across any research peptide order, see the supplier checklist.
Where to buy documented cagrilintide
V8 Peptides supplies cagrilintide as a lyophilized powder verified to ≥98% purity by HPLC with mass-spectrometry-confirmed identity, accompanied by a batch-specific Certificate of Analysis with every order, shipped domestically. The vial is available on the cagrilintide research vial product page.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.